MILLENDO THERAPEUTICS INC's ticker is MLND and the CUSIP is 60040X103. A total of 58 filers reported holding MILLENDO THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.18 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $439,000 | -79.1% | 83,119 | -73.4% | 0.11% | -74.7% |
| Q4 2019 | $2,105,000 | -19.5% | 312,279 | -15.1% | 0.43% | -17.8% |
| Q3 2019 | $2,616,000 | -44.7% | 367,935 | -10.1% | 0.52% | -40.4% |
| Q2 2019 | $4,730,000 | -27.7% | 409,146 | -10.9% | 0.88% | -30.8% |
| Q1 2019 | $6,543,000 | +99.2% | 459,146 | +0.0% | 1.27% | +83.9% |
| Q4 2018 | $3,285,000 | – | 459,145 | – | 0.69% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 1,396,615 | $11,103,000 | 2.86% |
| GREAT POINT PARTNERS LLC | 1,288,093 | $10,240,000 | 1.29% |
| Bpifrance SA | 1,078,670 | $8,575,000 | 1.10% |
| Prosight Management, LP | 256,739 | $2,041,000 | 1.05% |
| ADAMS STREET PARTNERS LLC | 459,145 | $3,285,000 | 0.69% |
| NEA Management Company, LLC | 1,766,779 | $14,046,000 | 0.56% |
| Samsara BioCapital, LLC | 45,101 | $359,000 | 0.34% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 64,794 | $515,000 | 0.23% |
| Worth Venture Partners, LLC | 25,951 | $206,000 | 0.16% |
| PA Capital LLC | 13,984 | $111,000 | 0.12% |